Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors

Bone Marrow Transplantation

Volumn 26, Issue 7, 2000, Pages 811-813

  Hilbe, W ^a   Nussbaumer, W ^b   Bonatti, H ^b   Thaler, J ^a   Niederwieser, D ^c   Nachbaur, D ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adverse event; G CSF; Healthy donor; Peripheral blood stem cell (PBSC) mobilisation

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CASE REPORT; CORYNEBACTERIUM; DONOR; FEMALE; HUMAN; INCISION; INFECTION; KLEBSIELLA; LEUKAPHERESIS; MALE; MOBILIZATION; PAIN; PERIANAL ABSCESS; PRIORITY JOURNAL; STAPHYLOCOCCUS; STEM CELL; SYMPTOMATOLOGY; TOOTH INFECTION;

EID: 0033754444     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702581     Document Type: Article

References (33)

1. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts
2. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft
3. Allogeneic blood stem cell transplantation: Consideration for donors
4. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation
5. Transplantation of allogeneic peripheral blood cells mobilized by recombinant human granulocyte colony-stimulating factor
6. Allogeneic blood cell transplants for haematological malignancy: Preliminary comparison of outcomes with bone marrow transplantation
7. Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies
8. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomised multicentre trial of the European group for marrow transplantation
9. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow
10. Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors
11. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: The MD Anderson Cancer Center experience
12. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals
13. Donor work-up and transport of bone marrow - Recommendations and requirements for a standardized practice throughout the world from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA)
14. G-CSF-induced mobilization of peripheral blood stem cells from healthy donors for allogeneic transplantation
15. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection
16. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: Differential effects and clinical implications
17. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment
18. Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides
19. Capillary leak syndrome likely the result of granulocyte-stimulating-factor after high-dose chemotherapy
20. Acute gouty arthritis following recombinant human granulocyte colony-stimulating factor in an allogeneic blood stem cell donor
21. Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor
22. Spontaneous splenic rupture following administration of granulocyte colony stimulating factor (G-CSF): Occurrence in an allogeneic donor of peripheral blood stem cells
23. Anaphylactoid reaction in a normal donor given granulocyte colony-stimulating factor
24. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor
25. Molecular basis of the autosomal recessive forms of granulomatous disease
26. Effect of granulocyte-macrophage colony-stimulating factor on sepsis-induced organ injury in rats
27. Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia
28. ARDS during G-CSF therapy for drug-induced agranulocytosis
29. Altered function and surface marker expression of neutrophils induced by rhG-CSF treatment in severe congenital neutropenia
30. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions
31. Inhibition of neutrophil apoptosis and modulation of the inflammatory response by granulocyte colony-stimulating factor in healthy and ethanol-treated human volunteers
32. Neutrophils activated by granulocyte colony-stimulating factor suppress tumor necrosis factor-alpha release from monocytes stimulated by endotoxin
33. Effect of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men